VIR - Vir Biotechnology, Inc.


9.1
-0.460   -5.055%

Share volume: 2,457,741
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$9.56
-0.46
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 02-26-2025 05-07-2025 11-05-2025 02-23-2026
Assets
Total Assets 1.399 B 1.308 B 1.019 B 1.003 B
Current Assets 1.042 B 932.207 M 545.684 M 514.080 M
Inventories 0.000 0.000 0.000 0.000
Other Current Assets 0.000 0.000 0.000 0.000
Short Term Investments 682.401 M 528.091 M 336.429 M 234.830 M
Total Receivables 0.000 0.000 0.000 0.000
Current Cash 222.947 M 273.571 M 170.084 M 232.185 M
Total Non-current Assets 190.015 M 218.140 M 304.212 M 314.575 M
Property Plant Equipment 63.183 M 61.681 M 58.203 M 55.620 M
Other Assets 293.172 M 313.839 M 415.566 M 433.123 M
Intangible Assets 0.000 0.000 0.000 0.000
Goodwill 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 1.399 B 1.308 B 1.019 B 1.003 B
Total liabilities 248.428 M 263.908 M 223.355 M 237.547 M
Total current liabilities 119.662 M 137.286 M 75.222 M 92.815 M
Accounts Payable 5.081 M 3.725 M 6.847 M 9.803 M
Other liabilities 128.766 M 126.622 M 138.700 M 144.732 M
Current long term debt 0.000 0.000 0.000 0.000
Long term debt 0.000 0.000 0.000 0.000
Other liabilities 128.766 M 126.622 M 138.700 M 144.732 M
Minority interest 0.000 0.000 0.000 0.000
Total Shareholder equity 1.150 B 1.044 B 796.098 M 765.276 M
Common stock 1.912 B 1.927 B 1.953 B 1.965 B
Retained earnings -759.784 M -880.749 M -1.155 B -1.198 B